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Abstract  
Skin is a major barrier against external insults and is exposed to combinations of chemical 
and/or physical toxic agents. Co-exposure to the carcinogenic benzo[a]pyrene (B[a]P) and solar 
UV radiation is highly relevant in human health, especially in occupational safety. In vitro 
studies have suggested that UVB enhances B[a]P genotoxicity by activating the AhR pathway 
and overexpressing the cytochrome P450 enzymes responsible for the conversion of B[a]P into 
DNA damaging metabolites. Our present work involved more realistic conditions, namely ex 
vivo human skin explants and simulated sunlight (SSL) as a UV source. We found that topically 
applied B[a]P strongly induced expression of cutaneous cytochrome P450 genes and formation 
of DNA adducts. However, gene induction was significantly reduced when B[a]P was 
combined with SSL. Consequently, formation of BPDE-adducts was also reduced when B[a]P 
was associated with SSL. Similar results were obtained with primary cultures of human 
keratinocytes. These results indicate that UV significantly impairs B[a]P metabolism, and 
decreases rather than increases immediate toxicity. However, it cannot be ruled out that 
decreased metabolism leads to accumulation of B[a]P and delayed genotoxicity.  
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Introduction 
Skin is the outer barrier of the body and plays a major defensive role against chemical and 
physical genotoxic agents. As a consequence, the main environmental carcinogen to the skin is 
solar ultraviolet (UV) light 1-3. UVB exposure is associated with direct DNA damage, namely 
cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) pyrimidone photoproducts (64PP) 
4. UVA, on the other hand, is more commonly associated with oxidative stress and oxidative 
DNA damage 5, but has also been shown to induce CPD 6-8, albeit in much lower quantities 
compared to UVB.  
Among the organic pollutants to which skin is exposed, polycyclic aromatic hydrocarbons 
(PAH) are ubiquitous molecules formed by incomplete combustion of organic material. 
Toxicity of PAH in skin is a major concern for occupational safety, where dermal contact is 
one of the main sources of exposure 9. PAH as parental compounds are inert. However, 
metabolization via phase I enzymes, mainly cytochrome P450 (CYP) oxygenases, convert PAH 
into reactive metabolite intermediaries 10. These metabolites then undergo conjugation by phase 
II enzymes, like glutathione-S-transferases (GST) and UDP-glucuronosyltransferases (UGT), 
to yield easily eliminated water-soluble compounds. Nevertheless, a fraction of phase I 
metabolites may diffuse to the nucleus and covalently bind to DNA forming PAH-DNA adducts 
11,12. Additionally, DNA damage may result from reactive oxygen species generated during the 
metabolic activation of PAH 13,14. The association of PAH exposure and cancer risk has been 
observed over the years 15, with the lungs 16, the bladder 17, and the skin 18 as the main targets. 
While many PAH pose a significant human health risk, benzo[a]pyrene (B[a]P) has been the 
most studied because of its established carcinogenicity in humans 19-21. A number of studies 
have focused on its highly carcinogenic metabolite, 7,8-dihydrodiol-
9,10-epoxy-benzo[a]pyrene (BPDE) 22-25. Like many other biological models, both in vitro and 
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in vivo experiments have shown that formation of DNA adducts occurs in skin exposed to B[a]P 
18,26,27. 
In regards to skin, the effects of PAH have to be discussed in terms of co-exposure with solar 
UV. The interaction between UV and PAH can be envisioned in different ways. First, PAH 
efficiently absorb UV radiation in the 290-400 nm region and can thus trigger photochemical 
reactions. PAH can be converted into photoproducts more toxic than their parental compounds 
28,29 or induce a photosensitized oxidative stress, as demonstrated in vitro 30-33. A less studied 
mechanism is how UV may modulate the formation of PAH-DNA adducts. It was first shown 
in vivo that chronic co-exposure of mice to UVA and B[a]P favored the formation of BPDE 
adducts 34. More recently, in vitro experiments have shown that UVB induced the expression 
of CYP1A1 and favored the formation of DNA adducts upon subsequent exposure to B[a]P 35. 
There is still a lack of data on the combined exposure to B[a]P and UV in human skin. We 
designed the present study to address this point using ex vivo skin explants. In order to mimic 
real-life exposure, epidermal explants were treated topically with B[a]P and irradiations were 
performed with simulated sunlight (SSL) rather than pure UVA or UVB. Similar experiments 
were performed with primary cultures of human keratinocytes. Here, we report on how SSL 
modulates metabolization of B[a]P and adduct formation, whether SSL irradiations were 
performed before or after B[a]P treatment.  
Results 
Treatment of human skin explants and keratinocytes by B[a]P or SSL only.    Ex vivo 
experiments were performed on skin explants collected from mammoplasty surgeries. Induction 
of metabolism was assessed by studying gene expression of Phase I and Phase II enzymes via 
quantitative reverse-transcription PCR (RT-qPCR). Genotoxicity was established through the 
quantification of BPDE-N2-dGuo, the most frequent BDPE-DNA adduct. No information was 
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gathered on oxidative lesions, which were shown to be much less frequent than BPDE-N2-dGuo 
upon exposure to pure B[a]P 36,37. After a series of experiments were performed where B[a]P 
was used in a dose-dependent manner (50-250 nmol) (data not shown), we chose a topical 
application of 100 nmol B[a]P, which was able to induce significant gene expression and 
BPDE-N2-dGuo formation. For SSL, we chose a dose of 2 MED, which corresponds to a 
relatively mild exposure likely to be encountered outdoors. 
In order to determine the changes in gene expression in response to B[a]P in skin, explants from 
8 different individuals were treated with 100 nmol of B[a]P over a time course of 72 hours. The 
shortest investigated time was 5 min, corresponding to samples exposed to B[a]P and collected 
as fast as possible. Expression of the phase I genes CYP1A1, CYP1A2, and CYP1B1 was then 
quantified (Table 1), using untreated samples as references. Immediately after treatment, B[a]P 
is shown to have no effect on the relative expression of these genes. Starting at 24 hours, 
treatment with B[a]P significantly increases the fold change of all three CYP genes, and their 
expression appears to be the greatest following 48 hours of B[a]P treatment. By 72 hours, 
expression of these genes is significantly decreased compared to 48 hours. Relative gene 
expression was compared with the formation of BPDE-N2-dGuo over the same time course 
from the same donor samples. HPLC-MS/MS quantification of these adducts following 
treatment with B[a]P revealed that formation of BPDE-N2-dGuo occurs in a time-dependent 
manner (Table 1). Expression of the phase I enzyme EPHX and the phase II enzymes GSTA1 
and GSTP1 was also studied. In general, EPHX1, GSTA1 and GSTP1 expression did not change 
drastically (Supplementary Table S1). 
< Table 1 > 
In order to observe if SSL had any effect on relative CYP expression levels in our ex vivo skin 
explant model, we performed RT-qPCR on SSL-irradiated samples. SSL had a small effect 48 
and 72 hours post-irradiation to increase expression of CYP1A1 and CYP1A2, but not CYP1B1 
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(Supplementary Figure S1a). There were no relative changes for SSL irradiation on these genes 
at earlier time points collected. Modulation of the expression of EPHX1, GSTA1 and GSTP1 
was never observed (data not shown). As expected, irradiation with SSL did not result in 
formation of BPDE-N2-dGuo. 
Normal human keratinocytes (NHK) were cultured from the skin of the same donors as those 
used to prepare explants. Toxicity assays showed that a B[a]P concentration of 1 µM led to a 
loss of viability lower than 10%. A SSL dose of 2 MED was slightly more cytotoxic, but led 
only to a moderate loss of viability (less than 25% at 24h) (Fig. Supplementary Figure S2). 
These conditions were thus used in all treatments of NHK. Exposure to B[a]P led to a strong 
increase in the expression of CYPs, which was detectable as early as 8 hours and was much 
more pronounced at 24 hours (Supplementary Table S2). Like in skin, CYP1A1 was the most 
over-expressed gene in HNK. However, contrary to skin, CYP1B1 was more upregulated than 
CYP1A2. Exposure to 2 MED SSL slightly increased expression of CYP genes (fold change 
2.9, 1.4 and 1.8 for CYP1A1, CYP1A2, and CYP1B1, respectively), but without reaching 
statistical significance, contrary to skin results. Increase in expression of metabolization genes 
upon B[a]P treatment was associated with the formation of B[a]P adducts (Supplementary Fig. 
S3). The level of BPDE-N2-dGuo increased in a time-dependent manner between 0 and 24 
hours. Interestingly, the maximal level of adducts was not observed for the largest concentration 
investigated (5 µM), but rather at 1 µM. Exposure to SSL resulted in a very low overexpression 
of CYP1A1 and 1B1 by a factor of 2, but not of CYP1A2 (Supplementary Figure S1b). No 
modulation of the expression of EPHX1, GSTA1 and GSTP1 was observed (data not shown). 
SSL strongly reduces the B[a]P-mediated induction of CYP genes in skin.    In order to 
determine what effect SSL has on cutaneous B[a]P metabolism, we compared gene expression 
results for explants that were treated with B[a]P versus the combination of B[a]P and SSL (Fig. 
1). In addition to exposure to either SSL or B[a]P only, two treatment protocols were used: i) 
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SSL followed 1 hour later by B[a]P exposure (SSL/B[a]P) and ii) incubation with B[a]P for 24 
hours followed by UV exposure (B[a]P/SSL). The 24-hour delay after B[a]P exposure was 
chosen because it corresponds to the beginning of the induction of CYP genes. The time of 1 
hour after SSL was selected because UV is known to induce a fast cellular response. 
Appropriate control samples were either exposed to vector (acetone) only, pure B[a]P or 
irradiated with SSL only. 
< Figure 1 > 
Over the time period investigated, it was observed that SSL reduced the stimulation of gene 
expression induced by B[a]P of CYP1A1 and CYP1A2, particularly at 48 hours and to a lesser 
extent at 72 hours, regardless of the treatment protocol used (Fig. 2 and 3). For the SSL/B[a]P 
and the B[a]P/SSL protocols, the induction of these two genes represented 30 to 40% of that 
determined for pure B[a]P. A decreased expression of approximately 50 to 60% was still 
observed at 72 hours. Reduced expression of CYP1B1 was only observed in the SSL/B[a]P 
protocol. We also looked to see if EPHX1, GSTA1, or GSTP1 were altered in their mRNA 
expression by SSL when performed with B[a]P (Table S1). None of the combined treatments 
had significant effect on any of these Phase I or Phase II genes. It was only observed that GSTP1 
was slightly increased at 48 hours when human skin explants were treated by the B[a]P/SSL 
protocol.  
< Figure 2 > 
< Figure 3 > 
SSL reduces the formation of BPDE-N2-dGuo in human skin.    We then quantified BPDE-
adducts by HPLC-MS/MS in the DNA of human explants treated with the different protocols. 
BPDE-N2-dGuo was unambiguously detected on the chromatograms. Analyses clearly showed 
a drastic effect of co-exposure of B[a]P with SSL on the amount of adducts (Supplementary 
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Fig. S4). In the time-course studies, irradiation with SSL appears to reduce formation of BPDE-
N2-dGuo compared to B[a]P treatment alone. Under the SSL/B[a]P protocol, the amounts of 
BPDE-N2-dGuo are significantly lower at 24 and 48 hours post-irradiation compared to B[a]P 
treatment alone (Figure 4a). The decrease at 48 hours is 5-fold. A lower level was also observed 
at 72h but the difference did not reach statistical significance. We checked that the time between 
the end of the exposure to SSL and the addition of B[a]P, set at 1 hour in our basic protocol, 
did not affect the response (Supplementary Fig. S5). These data suggest a limited contribution 
of cell lethality on the effect of SSL on B[a]P metabolism. Indeed, the deleterious cellular 
processes which may ultimately lead to cell death triggered by irradiation are much more 
advanced 8 h than 1 h after exposure. The observation that the impact on metabolism is similar 
at these two time points is an indication of the limited impact of cytotoxicity on the observed 
reduction of formation of BPDE-DNA adducts. Under the B[a]P/SSL protocol, we observed 
reduced amounts of BPDE-N2-dGuo by factors of more than 2 at the 24 and 48 hour post-
irradiation time points in the samples with combined treatment versus treatment only with B[a]P 
(Figure 4b). By 72 hours, namely 96 h hours after the beginning of the B[a]P exposure, the 
samples treated with B[a]P, regardless of the combination or not with SSL, show the same 
amount of DNA damage (Figure 4b), thus suggesting that SSL exposure of human skin treated 
with B[a]P delays formation of BPDE-N2-dGuo. 
 
< Figure 4 > 
Modulation of gene expression by SSL in B[a]P-treated NHK.    Treatment of NHK 
following either the SSL/B[a]P or B[a]P/SSL protocols led to a reduced induction of CYP genes 
than exposure to pure B[a]P (Fig. 5). This is observed for CYP1A1, CYP1B1, and CYP1A2 at 
24, 48, and 72 hours. The ratio with respect to B[a]P only treated samples was more than 3 for 
CYP1A1 and CYP1B1 in the SSL/B[a]P protocol. Like in skin, the delay between the end of the 
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irradiation and the addition of B[a]P did not modify the observed inhibition of BPDE-DNA 
adducts (Supplementary Fig. S5). The reduced gene induction effect was even larger in the 
B[a]P/SSL protocol were factors higher than 10 were observed at 48 and 72 hours post UV-
irradiation. In contrast, no significant variation in the expression of GSTA1, GSTP1 or EPHX1 
was observed (data not shown). 
< Figure 5 > 
Decreased formation of BPDE-N2-dGuo in NHK treated by combination of SSL and 
B[a]P.    SSL was also found to lead to a decrease in the yield of adducts produced in DNA 
upon exposure to B[a]P (Fig. 6). When exposure to SSL was performed 1 hour before addition 
of B[a]P, a very significant 5-fold difference on the level of BPDE-N2-dGuo was observed at 
24 hours, and to a lesser extent at 48 hours (ratio 1.6). At 72 hours, the difference lost statistical 
significance. The impact of SSL on the formation of BPDE-N2-dGuo was even stronger when 
irradiation was performed 24 hours after the beginning of the B[a]P treatment. Indeed, while 
the level of adducts kept increasing in non-irradiated NHK, it remained constant in the cells 
exposed to the B[a]P/SSL protocol. The ratio between the level of adducts in cells only exposed 
to B[a]P and those exposed to the B[a]P/SSL treatment rose from 1.8 at 24 hours post UV to 
2.4 at 72 hours. 
< Figure 6 > 
Effect of SSL and UVB on the formation of BPDE-dGuo adducts in HaCaT cells.    We 
treated HaCaT cells under conditions which were not more cytotoxic than in NHK 
(Supplementary Table 3). BPDE-N2-dGuo was found to be produced in an almost 10-times 
larger yield than in primary keratinocytes. Exposure of cells to SSL either 1 hour before or 24 
hours after treatment with B[a]P resulted in a significant decrease in the formation of BPDE-
N2-dGuo in DNA (Supplementary Fig. S6a). Exposure to UVB at a dose of 6 mJ/cm2 resulted 
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in a decrease in the level of adduct at 48 hours when irradiation was performed before B[a]P 
treatment (Supplementary Fig. S6b). This UVB dose did not modulate the level of adducts at 
earlier times points or when exposure to UVB occurred after B[a]P treatment. The higher dose 
of UVB (20 mJ/cm2) led to a lesser decrease in the level of BPDE-N2-dGuo (Supplementary 
Fig. S6c). 
 
Discussion 
The combined effects of UV and PAH in skin has major implications in human health, 
particularly in occupational safety. Indeed, cutaneous exposure is a much more important 
contamination source in workers than in the general population. As a consequence, their skin is 
more likely to experience exposure to solar UV in the presence of PAH. In order to provide 
valuable data on this subject, we performed a series of ex vivo and in vitro experiments aimed 
at determining whether exposure to solar UV radiation modulates the metabolization of B[a]P 
and the formation of BPDE-N2-dGuo after B[a]P treatment. 
The first part of our study involved explants made from freshly collected human skin. While 
there have been numerous studies of B[a]P metabolism performed in animal models, human 
skin has been less used as a working model. Costa et al. 38 used punch biopsies of abdominal 
skin to test the effect of B[a]P on expression of CYP1A1. Brinkmann et al. 39 also used human 
skin to test out genotoxic effects of B[a]P, particularly on metabolite formation and DNA 
damage, as determined by the comet assay. In order to provide further insights of the effects of 
B[a]P in skin, we first quantified the expression of various genes involved in xenobiotic 
metabolism. Emphasis was placed on classical metabolic enzymes CYP1A1, CYP1B1, and 
CYP1A2 found in the skin and other organs 40,41. We also included other genes expressed in 
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skin, such as GST and EPHX 39,42,43. Expression of these same genes was also quantified in 
human keratinocytes grown from the skin of the same donors. 
In agreement with Costa et al. 38, our RT-qPCR analyses unambiguously showed that exposure 
of human skin and NHK 41,44 to B[a]P results in a time-dependent increase of CYP1A1, 
CYP1A2, and CYP1B1. A lag period of less than 24 hours and a maximal expression at 48 hours 
were observed in skin. Induction of metabolism genes was faster in NHK with a lag phase of 8 
hours and a maximal expression at 24 hours. Interestingly, induction of CYP1A2 in skin was 
found to be much larger than that of CYP1B1, whereas an opposite trend was found in NHK, 
similar to other cell types 36. No significant modulation of the expression of phase II enzymes 
was observed. The temporal pattern observed for the formation of BPDE-N2-dGuo in skin also 
included a lag phase of approximately 24 hours and then reached a maximum at 72 hours. The 
shape of the time-course of formation of BPDE-N2-dGuo formation exhibiting a lag phase are 
reminiscent of data obtained in numerous cell types 36,37,45,46. It corresponds to an induction 
period of phase I metabolization enzymes clearly observed on the time-course for gene 
expression which is maximal after 48 hours. Consequently, the production of metabolites with 
DNA-damaging capacities does not take place immediately after the beginning of the treatment. 
It may be added that the level of adducts tends to decrease after 72 hours. This likely reflects 
the repair of BPDE-N2-dGuo via nucleotide excision repair, which is quite slow 47,48. 
Altogether, these data validate that ex vivo human skin explants are suitable model for studying 
PAH metabolization and genotoxicity under our experimental conditions. 
We then investigated the impact of exposure to SSL on B[a]P-mediated stimulation of 
metabolization and genotoxicity of B[a]P, which has yet to be studied. Based on available 
literature, we anticipated significant synergistic effects. Experiments in mice involving chronic 
exposure to B[a]P and UVA showed synergistic effects on the formation of B[a]P adducts 34, 
possibly due to decreased repair capacities. Moreover, UVB was found to increase expression 
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of CYP1B1 in human keratinocytes 44 and HaCaT cells 49, and it was suggested that this occurred 
through a signal transduction pathway involving photoactivated tryptophan and its oxidation 
photoproduct 6-formylindolo[3,2-b]carbazole (FICZ), a known ligand of the AhR 49,50. Katiyar 
et al. 42 reported that CYP1A1 and CYP1B1 were induced following UV exposure at both the 
gene and protein level in human epidermis. Finally, Nair et al. 35 observed that UVB exposure 
of HaCaT cells favored the formation of BPDE adducts following B[a]P treatment. 
Accordingly, we report that UV alone increases expression of CYP1A1 by a factor 
approximately 5 in skin and 2 in NHK, in the same range of low values observed by others 
35,42,49,51. It should be stressed that this stimulation of the expression of CYP genes remains 
modest compared to the almost two orders of magnitude larger expression following B[a]P 
treatment. 
We did not observe the same modest stimulation of CYP expression by SSL in the combination 
with exposure to B[a]P either before or after irradiation. Our experiments involving irradiation 
followed by B[a]P treatment rather showed that preliminary irradiation of skin explants strongly 
inhibited the induction of Phase I CYP1A1, CYP1A2, or CYP1B1 metabolism genes. Reduced 
expression of metabolic genes is associated with a lower level of BPDE-N2-dGuo in skin 
exposed to both SSL and B[a]P compared to those exposed to B[a]P only. This result 
unambiguously shows that UV decreased the metabolite load in the skin exposed to the 
SSL/B[a]P protocol. The same was true for the converse B[a]P/SSL protocol. Therefore, we 
can conclude that SSL has a repressive effect on B[a]P-induced metabolism in our ex vivo skin 
model. The response of skin explants seems thus to be drastically different from that of HaCaT 
cells, where combined UVB/B[a]P treatment was reported to favor formation of BPDE-DNA 
adducts. 35. 
The differences between our observations in explants and published in vitro data could have 
been explained by the fact that most keratinocytes in skin are differentiated and may exhibit 
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different metabolizing properties from cultured cells. This possibility led us to investigate the 
effect of a combined exposure to SSL and B[a]P in cultured, undifferentiated keratinocytes 
taken from the same skin samples. We made the same observations of a decreased expression 
of CYP genes and formation of BPDE-N2-dGuo in this model as in skin. This was expected 
since keratinocyte is the main cell type responsible for metabolism of xenobiotics in skin. Our 
results also show that differentiation and cutaneous environment do not explain the differences 
between our results and the published in vitro increase in B[a]P-DNA adduct in UV-exposed 
cells 35. 
The main difference between our work and that reporting the favored formation B[a]P-DNA 
adducts in UV-exposed cells is the cellular model. While we used human skin explants and 
primary cultures of human keratinocytes, other works involved the keratinocyte cell line HaCaT 
35 known to be mutated, particularly in the P53 gene. We also observed that HaCaT are more 
metabolically active than NHK since they induce an almost 10-time larger amount of BPDE-
N2-dGuo. In order to determine whether the discrepancies were explained by the difference in 
models, we applied the SSL/B[a] and B[a]P/SSL protocols to HaCaT cells. A strong inhibition 
in the formation of adducts was observed when compared to treatment with pure B[a]P, like in 
skin and NHK. Another difference between our work and previously published data was the 
nature of the radiation applied to the samples. Instead of the more biologically relevant SSL, 
the authors used UVB. We thus repeated the co-treatment protocols on HaCaT with UVB 
instead of SSL. A low dose of 6 mJ/cm2, similar to that used by Nair et al. 35, was applied and 
we also observed a decrease, rather than an increase, in the level of B[a]P adducts when 
irradiation was performed before B[a]P treatment. A larger UVB dose (20 mJ/cm2) was also 
used, which resulted also in a decreased formation of BPDE-N2-dGuo upon B[a]P treatment, 
although to a lesser extent than with SSL or 6 mJ/cm2 UVB. These observations show that UVB 
is less efficient than UVA at inhibiting the formation of DNA adducts, at least in HaCat cells. 
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However, this does not explain why increased formation of adducts was reported with UVB 35. 
One possible explanation may be the difference in the assays used for the quantification of DNA 
adducts. While we directly targeted them in enzymatically hydrolyzed DNA, the previous work 
relied on an indirect measurement based on HPLC-fluorescence detection of B[a]P-tetraol 
released by acidic hydrolysis of extracted DNA. Another difference is that irradiations in the 
previous work were performed in phenol-free DMEM medium while we used PBS in order to 
prevent any photosensitization processes. Altogether, we could confirm in HaCaT cells the 
inhibitory effects of UV on the metabolism and genotoxicity of B[a]P that we observed in skin 
and NHK. 
Our results on skin and NHK show that when a UV source mimicking sunlight is used, no 
increased metabolization and genotoxicity of added B[a]P takes place. Yet, as observed by 
others 35,42,49,51, SSL alone lead to a small over expression of CYP genes. These results suggest 
that the endogenous photoproducts mediating the activation of B[a]P metabolism are either 
weak ligands of AhR or produced in low amounts since exogenous ligands efficiently compete 
for the binding to AhR. Consequently, the role of FICZ in the effects of combined exposures to 
UV and B[a]P or other PAH may be smaller than anticipated 35,50,51. Actually, the presence of 
this compound in skin has never been shown. Formation of FICZ has only be detected in vitro 
in HaCaT cells under non-physiological conditions 49. In addition, it should be reminded that 
tryptophan is a rare amino acid amongst the less frequent ones in proteins 52. We recently 
published that FICZ is a minor photoproduct of tryptophan 53 partly because its formation 
requires addition of two tryptophan photoproducts54 and its yield depends quadratically on the 
dose. The fact that SSL irradiation exhibits a strong inhibitory effect when applied 24 hours 
after BaP treatment (B[a]P/SSL protocol), namely when the AhR pathway has been extensively 
triggered, reinforces the idea of a limited role of the FICZ in the modulation of B[a]P 
metabolism in skin. 
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Alternative explanations have thus to be found to our observations. Obviously, FICZ-mediated 
activation of AhR cannot account for our results. Photoproducts arising from various cellular 
components may yet play a role in the inhibition the metabolization of B[a]P, but rather as 
competitor with CYPs, as observed in mixtures of PAH 55-58. However, the latter process does 
not explain the massive reduction in expression of CYP genes. More general cellular stresses 
may also be involved, rather than a cellular response involving specific pathways. First, the 
reduced expression of CYP genes could be explained by the well-documented temporary arrest 
in RNA synthesis in transcribed genes that takes place following UV irradiation 59-61. Another 
explanation could be related to the ability of UV to deplete the cellular nicotinamide adenine 
dinucleotide (NADH) pool 62. This important biological factor is key in the production of ATP 
and in the cellular energy content 63. It seems likely that reduced energy level leads to decrease 
metabolization capacities. NADH is also a major cofactor as a reductant in the enzymatic 
mechanism of CYP450 64. Therefore, decreased intracellular NADH concentration could 
explain the decreased metabolization of B[a]P. The observation of similar effects when SSL is 
applied either before or after B[a]P treatment also rules out a major contribution of 
photodegradation of the PAH since B[a]P is never irradiated in the SSL/B[a]P protocol. 
In conclusion, our study provides for the first time an extensive picture of the impact of SSL, 
namely a combination of both UVB and UVA components, on the metabolism and genotoxicity 
of B[a]P. In contrast to previous data obtained in vitro with pure UVB, solar UV radiation 
appears to have a strong repressive effect on B[a]P-induced gene induction of CYP enzymes 
and delays formation of BPDE-DNA adducts in skin. Although positive in terms of immediate 
impact, this result may also suggest that parent PAH accumulate longer in irradiated skin. 
Indeed, only metabolites are actively eliminated from the epidermis 65. Therefore, it is possible 
that UV exposure converts an acute exposure to a high dose into a more chronic exposure to a 
lower dose. It is unclear what impact this would have on influencing or initiating skin cancer. 
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Another possible mechanism to increased genotoxicity upon co-exposure to PAH and UV is an 
impact on the formation and repair of bipyrimidine photoproducts. We are currently working 
on this topic by using an approach similar to that used in the present work. 
 
Methods 
Skin explants preparation.    Human skin samples were obtained following breast surgery 
from heathy female donors with their informed consent (Centre Hospitalier Universitaire de 
Grenoble, Grenoble, France). All experiments were performed in accordance with relevant 
guidelines and regulations. In particular, work was performed in agreement with article 
L1245-2 of the French Public Health Code on the use of surgical wastes for research purposes. 
It stipulates that donors must be informed and agree; and that samples are used anonymously. 
Collection and storage of human skin samples was declared to the French authorities and 
validated in the CODECOH DC-2008-444 document. All donors were between the ages of 17-
58, and their skin phototype was between I and III, according to the Fitzpatrick classification 
scale 66. Skin samples were handled as previously described 7. Epidermal skin was 
dermatomized to a 0.25 mm thickness using a SOBER hand-held dermatome (Humeca, 
Enschede, Netherlands), and then 12-mm punch biopsies were made. Samples were placed in 
12-well plates and maintained via liquid/air interface in DMEM/F-12 medium (Thermo-Fisher) 
containing 10% Pen/Strep at 37°C in a humidified incubator containing 5% CO2.  
UV irradiation of human skin explants.    SSL irradiations were performed using a LS1000 
Solar Simulator (Solar Light Company, Glenside, PA), which emitted wavelengths in the 290-
400 nm range. Live radiation intensity was measured using the Erythema Meter, and displayed 
as live intensity (minimal erythema dose (MED)/hr). In all experiments, the dose of 2 MED 
was used for all irradiated samples. Prior to irradiation, culture media was removed and the 
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samples were rinsed twice with PBS. Irradiations were performed at room temperature in PBS 
via liquid/air interface without the plate cover. Following irradiations, PBS was replaced with 
fresh culture medium, and the samples were kept in the incubator until their collection time, 
when explants were halved. One series of samples was not replaced in the incubator but frozen, 
corresponding to a post-irradiation time of 5 min. Samples for DNA damage quantification 
were immediately frozen at -20°C whereas samples used for gene expression analysis were 
stored at -80°C in RNAlater (Thermo Fisher).  
Treatment of skin.    Different treatment protocols were applied to the skin explants: i) 
Exposure to SSL only, II) exposure to B [a]P only, iii) SSL exposure followed 1 hour later by 
B[a]P treatment (SSL/B[a]P), and iv) incubation with B[a]P for 24 hours followed by exposure 
to SSL (B[a]P/SSL). For samples treated under the SSL/B[a]P protocol, SSL irradiations were 
performed immediately following biopsy preparation. After irradiation, samples were 
maintained in PBS in the incubator for 1 hour. PBS was removed, and samples were treated 
with vector (100% acetone, Sigma-Aldrich, Lyon, France) or 5 µL of a 20 mM B[a]P (Sigma-
Aldrich) solution. Fresh culture medium was added and samples placed in the incubator. They 
were collected after increasing periods of time. One series of samples was not placed in the 
incubator but frozen immediately, corresponding to a post-irradiation time of 5 minutes. For 
samples treated under the B[a]P/SSL protocol, pre-treatment with vector (100% acetone) or 5 
µL of 20 mM B[a]P was performed immediately following biopsy preparation. Fresh culture 
media was added to each well and the samples were maintained in the incubator. Twenty-four 
hours later, culture medium was removed, and the biopsies were gently washed twice in PBS. 
SSL irradiations and samples collection was performed after increasing periods of time. One 
series of samples was not placed in the incubator but frozen immediately, corresponding to a 
post-irradiation time of 5 minutes. For all treatment protocols, the minimum number of human 
donors was 3, with samples collected in triplicates. 
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Treatment of cultured keratinocytes.    Keratinocytes were obtained from fresh human skin 
samples, as previously described 7. Cells were grown in KSF medium containing 1% Pen/Strep, 
25 µg/mL bovine pituitary extract (BPE), and 0.9 ng/mL of recombinant human epidermal 
growth factor (EGF). BPE and EGF were removed from the cell culture media 24 hours before 
treatment or irradiation, and throughout the experiment performed. For samples treated under 
the SSL/B[a]P protocol, keratinocytes were rinsed twice in PBS and exposed to 2 MED SSL in 
PBS. They were then maintained in PBS in the incubator for 1 hour. B[a]P dissolved in DMSO 
was then added to reach a final concentration of 1 µM (Sigma-Aldrich). Samples were collected 
after increasing periods of time. Untreated controls were incubated with pure DMSO. For 
samples treated under the B[a]P/SSL protocol, pre-treatment with vector (DMSO at a final 
concentration of 1 %) or 1 µM B[a]P was performed in the incubator. Twenty-four hours later, 
culture medium was removed and the cells were washed twice in PBS. SSL irradiations and 
samples collection was performed, as described above. For both protocols, one series of samples 
was not placed in the incubator after irradiation but frozen immediately, corresponding to a 
post-irradiation time of 5 min. 
Quantitative reverse transcription PCR.    Gene expression analysis was performed on phase 
I (CYP1A1, CYP1A2, CYP 1B1, and EPHX1) and phase II (GSTA1 and GSTP1) metabolism 
genes. Total RNA was extracted following treatment by homogenizing the skin with the 
TissueRuptor, Proteinase K digestion, QiaShredder column, and RNeasy Mini Kit combined 
with the RNase-free DNase system (Qiagen, Courtaboeuf, France). RNA samples were 
quantified using a ND1000 NanoDrop spectrophotometer. First strand cDNA was synthesized 
from 1.0 µg of total RNA using the SuperScript VILO Synthesis Kit (Thermo-Fisher), and 
quantitative real-time polymerase chain reaction (RT-qPCR) was performed using the 
appropriate human RT2 qPCR primers and RT² SYBR Green qPCR Mastermix (Qiagen). 
Amplification was performed using the Bio-Rad CFX96 system (Bio-Rad, Marnes-la-Coquette, 
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France). The cycle threshold (CT) values were determined using the Bio-Rad CFX96 system 
software, and the comparative ΔΔCT method was used to calculate the relative fold change of 
all genes after normalization to GAPDH, RPS18, or β-Actin (Livak and Schmittgen, 2001). 
Biological triplicates were processed individually for RNA isolation and analyzed in technical 
duplicates. Values were normalized to expression in control (untreated) samples. 
Quantification of BPDE-N2-dGuo.    For DNA extraction, samples were homogenized using 
the TissueLyzer II and extracted using the DNeasy Blood and Tissue Kit, both from Qiagen. 
Explants or cell pellets were homogenized using the ATL lysis buffer combined with 
mechanical disruption using metal beads, followed by treatment with proteinase K. Samples 
were then treated with RNase-A before a second lysis step using AL buffer, before loading onto 
DNeasy spin columns. DNA was eluted off the column by adding 200 µL of water in two 
separate, consecutive centrifugations. Samples are then freeze-dried overnight at -20°C and 
then rehydrated the next day in 50 µL of water. Hydrolysis of DNA samples was performed 
using a cocktail of enzymes. The first incubation was performed using phosphodiesterase II, 
DNase II, and nuclease P1 (37°C, 30 minutes). The second incubation step was then performed 
using phosphodiesterase I and alkaline phosphatase (37°C, 2 hours). All enzymes used were 
purchased from Sigma-Aldrich. 
Samples were then injected on an HPLC system (Agilent, Massy, France) connected to a 
reverse-phase HPLC column (150 x 2 mm ID, 3 μm particle size, ODB, Interchim, Montluçon, 
France). The mobile phase was a gradient of acetonitrile (6 to 80%) in 2 mM ammonium 
formate (pH 6). BPDE-N2-dGuo was detected by a tandem mass spectrometer (SCIX API 3000) 
using transitions m/z 570257 and m/z 570454 as previously described 36,37,67. Unmodified 
nucleosides were quantified with a UV detector. External calibration of the response of the 
detector was performed for each run of analyses. Repeated injections of standards during the 
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run permitted to control the stability of the sensitivity of the detection and of the retention times. 
Results were expressed in number of adducts per million normal bases.  
Culture and treatment of HaCaT cells. HaCaT cells were grown in DMEM medium in the 
presence of Pen/Strep and FBS (10% v/v). For treatment, cells were grown in 6 cm diameter 
petri dishes. Prior to irradiation, the medium was removed and replaced by PBS. Exposure to 
SSL was performed by using a LS1000 Solar Simulator (Solar Light Company, Glenside, PA) 
with a dose rate of 6 MED/h. UVB irradiations were performed with a 2x15 W UVB lamp 
exhibiting an emission spectrum centered at 312 nm. The dose rate was 70 mJ/cm2 per min. For 
the treatment with B[a]P, cells were placed in culture medium without FBS. A stock solution 
of B[a]P in DMSO was added to reach the selected concentration.  In all experiments, cells 
were collected after 24 and 48 hours post-treatment. MTT tests and quantification of BPDE-
N2-dGuo were performed, as previously described for keratinocytes. Similar protocols were 
used for the combination experiments with SSL set at 2 MED, UVB used at either 6 or 20 
mJ/cm2 and B[a]P at 1 µM. 
Statistical analysis.    Statistical analysis were performed on pools of replicates originating 
from different donors. Data were statistically analyzed in GraphPad PRISM using paired t-tests 
with non-parametric Wilcoxon, or one-way ANOVA followed by Student-Newman-Keuls 
(SNK) for multiple comparisons. 
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Tables 
 
Table 1: Effects of pure B[a]P and SSL in human skin. For gene expression, data were collected 
from 8 individual donors. Samples were normalized to GAPDH used as a reference gene. 
Formation of BPDE-N2-dGuo was inferred from the analysis of 6 to 12 donors. 
 
CYP1A1 CYP1A2 CYP1B1 BPDE-N2-dGuo 
Mean fold increase ± SEM  
adducts/106 bases 
± SEM  
B[a]P 5 min 1.1 ± 0.1 1.3 ± 0.3 1.1 ± 0.2 0.0 ± 0.0 
B[a]P 24h 18.6 ± 5.3 1 10.3 ± 3.5 1 9.5 ± 2.1 1,4 1.6 ± 0.4  1 
B[a]P 48h 70.0 ± 19.4 1,2 59.3 ± 12.3 1,3,4 11.9 ± 1.3 1,4 22.6 ± 9.2 1,6 
B[a]P 72h 10.6 ± 2.0 1 13.0 ± 7.1 5 4.0 ± 0.2 1 36.9 ± 11.7  3,5 
1
Statistically different compared to 5 min (p<0.01); 
2
Statistically different compared to 24h and 72h 
(p<0.01); 
3
Statistically different compared to 24h (p<0.05); 
4
Statistically different compared to 72h 
(p<0.01); 
5
Statistically different compared to 5 min (p<0.05); 
6
Statistically different compared to 24h 
(p<0.01) 
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Figure Legends 
 
Figure 1. Schematic representation of experimental protocols performed. Treatment with B[a]P 
was performed topically in acetone at 100 nmol. Samples were exposed to a dose of 2 MED of 
SSL. Skin explants were prepared. Three protocols were used: i) B[a]P: explants were treated 
with B[a]P; ii) SSL/B[a]P: explants were exposed to SSL and then treated 1 hour later with 
B[a]P and iii) B[a]P/SSL: explants were treated with B[a]P, and then exposed to SSL 24 hours 
later.  
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Figure 2. Induction of the expression of CYP genes in skin is altered when irradiation with 2 
MED SSL is performed 1 hour before B[a]P treatment when compared to B[a]P treatment 
alone. Expression of genes was quantified at different time points by RT-qPCR at the indicated 
times post-treatment: a) CYP1A1, b) CYP1A2 and c) CYP1B1. Mean of at least three 
independent experiments ± SEM. Statistical significance: * p<0.05, ** p<0.01. 
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Figure 3. Induction of the expression of CYP genes in skin is altered when irradiation with 2 
MED SSL is performed 24 hours after B[a]P treatment when compared to B[a]P treatment 
alone. Expression of genes was quantified at different time points by RT-qPCR at the indicated 
times post-treatment: a) CYP1A1, b) CYP1A2 and c) CYP1B1. Mean of at least three 
independent experiments ± SEM. Statistical significance: * p<0.05, ** p<0.01. 
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Figure 4. Level of BPDE-N2-dGuo in the DNA of skin explants treated with different protocols 
a) SSL/B[a]P: exposure to 100 nmol B[a]P 1 hour after irradiation with 2 MED SSL and b) 
B[a]P/SSL: exposure to 100 nmol B[a]P for 24 hours followed by irradiation with 2 MED SSL. 
Data were from explants from three individual donors each treated in triplicate. A comparison 
was made between samples exposed to B[a]P alone or to B[a]P and UV (statistical significance 
*p<0.05; **p<0.01). 
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Figure 5. Induction of the expression of CYP genes in NHK is altered when irradiation with 2 
MED SSL is performed 24 hours after B[a]P treatment when compared to B[a]P treatment 
alone. Expression of the genes CYP1A1, CYP1A2 and CYP1B1 was quantified at different time 
points by RT-qPCR in different protocols a) exposure to 1 µM B[a]P 1 hour after irradiation 
with 2 MED SSL and b) exposure to 1 µM B[a]P for 24 hours followed by irradiation with 2 
MED SSL. The left side of both panel show data for unirradiated samples treated with B[a]P 
alone and the right side for the co-exposure protocols. Statistical significance of the differences 
were determined for each time point between the control and the irradiated samples. (p<0.05, 
** p<0.01). 
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Figure 6. Level of BPDE-N2-dGuo adducts in the DNA of cultured NHK treated with different 
protocols a) SSL/B[a]P: exposure to 1 µM B[a]P 1 hour after irradiation with 2 MED SSL and 
b) B[a]P/SSL: exposure to 1 µM B[a]P for 24 hours followed by irradiation with 2 MED SSL. 
Data obtained were from cells of three individual donors each treated in triplicate. A 
comparison was made between samples exposed to B[a]P alone or to B[a]P and UV (statistical 
significance *p<0.05; **p<0.01). 
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Supplementary Information 
 
1. Table S1: Expression of some Phase I and phase II enzymes in B[a]P-treated skin 
Table S1 shows the limited effect of B[a]P alone or in combination with SSL on the 
expression of EPHX1, GSTA1 and GSTP1. Data were collected from 3 or 4 individual donors. 
Samples were normalized to GAPDH used as a reference gene. Results are mean fold change 
± SEM. 
SSL/B[a]P 
 
24 h 48 h 72 h 
B[a]P SSL+B[a]P B[a]P SSL+B[a]P B[a]P SSL+B[a]P 
EPHX1 1.5 ± 0.6 0.8 ± 0.2 3.0 ± 2.1 0.8 ± 0.4 0.5 ± 0.0 0.2 ± 0.0 
GST A1 2.3 ± 1.2 1.3 ± 0.5 2.2 ± 1.4 1.3 ± 0.8 1.1 ± 0.5 1.8 ± 0.9 
GST P1 1.1 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 0.8 ± 0.1 1.0 ± 0.3 1.0 ± 0.0 
B[a]P/SSL 
 
24 h 48 h 72 h 
B[a]P SSL+B[a]P B[a]P SSL+B[a]P B[a]P SSL+B[a]P 
EPHX1 1.2 ± 0.1 1.4 ± 0.4 1.4 ± 0.4 1.2 ± 0.5 0.8 ± 0.0 0.1 ± 0.0 
GSTA1 3.1 ± 1.4 0.8 ± 0.4 2.8 ± 1.3 1.5 ± 0.5 1.1 ± 0.4 1.2 ± 0.8 
GSTP1 1.0 ± 0.1 1.1 ± 0.1 0.9 ± 0.1 1.5 ± 0.2 1 0.8 ± 0.2 0.8 ± 0.1 
1Statistically different from B[a]P 48h and from B[a]P+SSL 24h (p<0.05) 
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2. Figure S1. Induction of CYP genes upon exposure of pure SSL 
Skin explants (a) and NHK samples (b) were exposed to SSL in PBS and replaced in fresh 
medium. They were placed in the incubator for increasing period of times. Samples were then 
collected and expression of CYP genes was quantified by RT-qPCR. Reported values are 
means ± SEM (n=6). 
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3. Figure S2. Toxicity of B[a]P and SSL in NHK 
Dose- and time-dependent loss of viability in cultured NHK exposed to either a) SSL or b) 
B[a]P. panel c) is the extension for the low concentrations of the B[a]P data. Cellular viability 
was evaluated at 24, 48, or 72 hours using the MTT assay. Cells obtained from 6 individual 
donors were used and studied in triplicate. Results are % of viability with respect to untreated 
cells ± SEM. 
 
 
  
60
80
100
0 2 4 6 8 10
C
el
lu
la
r 
vi
ab
ili
ty
 (
%
)
B[a]P concentration (µM)
24 h
48 h
72 h0
25
50
75
100
0 50 100 150 200 250
ce
llu
la
r 
vi
ab
ili
ty
 (
%
)
B[a]P concentration (µM)
24 h
48 h
72 h
0
25
50
75
100
0 1 2 3 4 5
C
el
lu
la
r 
vi
ab
ili
ty
 (
%
)
SSL dose (MED)
24 h
48 h
72 h
a) b) c)
4 
 
4. Table S2: Expression of some Phase I and phase II enzymes in B[a]P-treated 
NHK 
Table S2 shows the effect of exposure of NHK to pure B[a]P on the expression of several 
genes. While CYP450 are efficiently overexpressed, other genes coding for other metabolism 
enzymes are not modulated (EPHX1, GSTA1 and GSTP1). Factors involved in induction of 
PAH metabolism (AhR and ARNT) do not appear to be modulated either. Data were collected 
from primary NHK cultures from 3 individual donors all studied in triplicates. Samples were 
normalized to GAPDH used as a reference gene. Results are mean fold change ± SEM. 
Time 2h 8h 24h 
B[a]P 0.2 µM 2 µM 0.2 µM 2 µM 0.2 µM 2 µM 
CYP1A1 10 ± 1 12 ± 1 51 ± 33 80 ± 64 155 ± 86 948 ± 317 
CYP1A2 4 ± 1 4 ± 2 8 ± 4 12 ± 7 17 ± 4 57 ± 22 
CYP1B1 8 ± 2 10 ± 2 42 ± 18 55 ± 35 97 ± 64 497 ± 227 
GSTA1 1.5 ± 0.4 1.4 ± 0.4 0.4 ± 0.1 0.5 ± 0.2 0.9 ± 0.6 0.6 ± 0.1 
GSTP1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 1.0 ± 0.2 1.2 ± 0.1 1.4 ± 0.1 
EPHX1 1.1 ± 0.1 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.0 0.9 ± 0.0 1.0 ± 0.1 
AhR 0.9 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.2 0.7 ± 0.1 0.6 ± 0.3 
ARNT 1.3 ± 0.3 1.3 ± 0.2 0.9 ± 0.1 0.9 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
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5. Figure S3. Formation of BPDE-N2-dGuo in B[a]P-treated NHK 
NHK were cultured from skin biopsies. They were then exposed to B[a]P dissolved in DMSO 
added to the culture medium. The final concentration ranged between 0.2 and 5 µM. After 
different periods of time, cells were collected, DNA extracted and the level of BPDE-N2-
dGuo determined by HPLC-MS/MS. Results are mean of three donors treated in triplicates ± 
SEM. The amount of BPDE-N2-dGuo in the control samples was below the detection limit. 
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6. Figure S4. HPLC-MS/MS detection of BPDE-N2-dGuo in skin 
The figure below shows typical HPLC-MS/MS chromatograms of the analysis of BPDE-N2-
dGuo in the DNA of skin explants exposed for 48 hours to 100 nmol B[a]P under different 
conditions. a) standard of BPDE-N2-dGuo (400 fmol) b) untreated control, c) samples 
incubated with B[a]P alone, d) samples exposed to 2 MED SSL 1 hour before the beginning 
of the B[a]P exposure (SSL/B[a]P protocol) and, e) samples exposed to 2 MED 24 hours after 
the beginning of the B[a]P treatment (B[a]P/SSL protocol). The traces shown are the total ion 
currents which represent the sum of three signals corresponding to specific fragments 
produced by BPDE-N2-dGuo in well-defined ratio. The chromatographic peaks were 
identified by comparison of the retention time and mass spectrometry features with those of 
the authentic standard. The amount of analyzed DNA was the similar (< 10% difference) in 
all samples. 
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7. Figure S5: Impact of the delay between exposure to SSL and B[a]P treatment on 
the formation of BPDE-N2-dGuo in DNA 
Skin explants and NHK were treated with the SSL/B[a]P protocol with varying period of 
times between the end of the irradiation and the addition of B[a]P in fresh medium. Results 
are compared with the level of adduct in unirradiated samples. In all cases, samples were 
collected 24 hours after the addition of B[a]P. Values are the mean ± standard deviation 
(n=6). 
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8. Table S3: Toxicity of SSL, UVB and B[a]P in HaCaT cells. 
Viability of HaCaT exposed to either SSL, B[a]P, or UVB. Results were obtained via MTT 
assay performed either 24 or 48 hours after treatment. Reported values are mean ± SEM 
(n=6). 
SSL (MED) 0 1 2 5 10 
24h 100±7 93±4 84±2 22±4 17±3 
48h 100±8 91±4 95±1 11±2 3±1 
BaP (µM) 0 0.5 1 2 5 
24h 100±2 100±3 98±5 111±2 102±3 
48h 100±5 107±7 100±5 113±4 138±7 
UVB (mJ/cm2) 0 10 25 50 100 
24h 100±3 93±2 83±2 76 61±4 
48h 100±3 95±3 95±3 98 86±3 
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9. Figure S6: Formation of BPDE-N2-dGuo adducts in HaCaT cells co-exposed to 
UV and B[a]P 
HaCaT were exposed in different ways. In the UV/B[a]P protocols, cells were irradiated and 
B[a]P was added after 1 hour. In the B[a]P/UV protocols, cells were incubated with B[a]P for 
24 hours, and then exposed to UV. Control samples only treated with B[a]P were also 
prepared. The reported values are mean ± standard deviation (n=3). 
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